FR2825090B1 - Derives chimiques et leur application comme agent antitelomerase - Google Patents

Derives chimiques et leur application comme agent antitelomerase

Info

Publication number
FR2825090B1
FR2825090B1 FR0106909A FR0106909A FR2825090B1 FR 2825090 B1 FR2825090 B1 FR 2825090B1 FR 0106909 A FR0106909 A FR 0106909A FR 0106909 A FR0106909 A FR 0106909A FR 2825090 B1 FR2825090 B1 FR 2825090B1
Authority
FR
France
Prior art keywords
application
chemical derivatives
antitelomerase
agent
antitelomerase agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0106909A
Other languages
English (en)
Other versions
FR2825090A1 (fr
Inventor
Herve Bouchard
Augustin Hittinger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0106909A priority Critical patent/FR2825090B1/fr
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Priority to PCT/FR2002/001767 priority patent/WO2002096903A2/fr
Priority to AU2002314252A priority patent/AU2002314252A1/en
Priority to JP2003500082A priority patent/JP2004534046A/ja
Priority to EP02740814A priority patent/EP1401833A2/fr
Publication of FR2825090A1 publication Critical patent/FR2825090A1/fr
Application granted granted Critical
Publication of FR2825090B1 publication Critical patent/FR2825090B1/fr
Priority to US10/721,210 priority patent/US6995175B2/en
Priority to US11/222,322 priority patent/US20060199840A1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0106909A 2001-05-28 2001-05-28 Derives chimiques et leur application comme agent antitelomerase Expired - Fee Related FR2825090B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR0106909A FR2825090B1 (fr) 2001-05-28 2001-05-28 Derives chimiques et leur application comme agent antitelomerase
AU2002314252A AU2002314252A1 (en) 2001-05-28 2002-05-27 Chemical derivatives and the use thereof as an anti-telomerase agent
JP2003500082A JP2004534046A (ja) 2001-05-28 2002-05-27 化学誘導体および抗テロメラーゼ剤としてのその使用
EP02740814A EP1401833A2 (fr) 2001-05-28 2002-05-27 Derives chimiques et leur application comme agent antitelomerase
PCT/FR2002/001767 WO2002096903A2 (fr) 2001-05-28 2002-05-27 Derives chimiques et leur application comme agent antitelomerase
US10/721,210 US6995175B2 (en) 2001-05-28 2003-11-25 Chemical derivatives and their application as antitelomerase agent
US11/222,322 US20060199840A1 (en) 2001-05-28 2005-09-08 Chemical derivatives and their application as antitelomerase agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0106909A FR2825090B1 (fr) 2001-05-28 2001-05-28 Derives chimiques et leur application comme agent antitelomerase

Publications (2)

Publication Number Publication Date
FR2825090A1 FR2825090A1 (fr) 2002-11-29
FR2825090B1 true FR2825090B1 (fr) 2003-08-01

Family

ID=8863666

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0106909A Expired - Fee Related FR2825090B1 (fr) 2001-05-28 2001-05-28 Derives chimiques et leur application comme agent antitelomerase

Country Status (1)

Country Link
FR (1) FR2825090B1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108191832B (zh) * 2018-01-04 2019-08-27 南方医科大学 一种双喹啉二聚体盐衍生物及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5863936A (en) * 1995-04-18 1999-01-26 Geron Corporation Telomerase inhibitors
DE19935219A1 (de) * 1999-07-27 2001-02-01 Boehringer Ingelheim Pharma Carbonsäureamide, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Herstellung

Also Published As

Publication number Publication date
FR2825090A1 (fr) 2002-11-29

Similar Documents

Publication Publication Date Title
FR20C1039I2 (fr) Derives de l'uk-2a
DE60207627D1 (de) Überzug und Überzugszusammensetzung
IS6858A (is) Trísólpýridín sem bólgueyðandi efni
ID30393A (id) Senyawa tienopirimidina, pembuatan dan penggunaannya
DE60204857D1 (de) Flüssigkeitszerstäuber
NO20034490D0 (no) Fremgangsmåte for sammensetting av absorberende gjenstand til personlig stell
ATE555761T1 (de) Absorbierender artikel
DE60209850D1 (de) Absorbierender Artikel
DE60214783D1 (de) Absorbierender Gegenstand
DE60233192D1 (de) Hydrophobe und lipophobe zusammensetzung
FR2830516B1 (fr) Suspension de turboreacteur
BR0201972B1 (pt) montante de suspensão.
DE60225452D1 (de) Wiederverschliessbarer absorbierender artikel
PT1250321E (pt) Composicao de gliburida
ITMI20021834A1 (it) Sospensione di apparecchiature
DE60208700D1 (de) Schälgerät und zugehörige verfahren
DE50214244D1 (de) Klauenpolläufer und dessen herstellverfahren
FI20011300A (fi) Sprinkleri
DE60215580D1 (de) Absorbierender Artikel
NO20041968L (no) Anvendelse av cystationin
BR0209263B1 (pt) composições de revestimento compreendendo produtos de carbono de área t alta
FI20010075A (fi) Terveysvaikutteinen tuote ja menetelmä
DE60233109D1 (de) Radidentifikator- ortungsverfahren
NO20035605D0 (no) Pediatrisk formulering av gatifloxacin
LU90483B1 (fr) Compositions nouvelles de m-thanesulfonate de parox-tine

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 15

ST Notification of lapse

Effective date: 20170131